IDNA
iShares Genomics Immunology and Healthcare ETF · PSE
- Category Equity
- Expense Ratio 0.47%
- Listing Date Jun 13, 2019
- Volume 26,173.0
- Market Cap (AUM) $131.78M
Performance
-6.43%
1W
-6.05%
1M
-6.42%
3M
-3.94%
6M
+0.94%
YTD
+14.07%
1Y
Top Holdings
-
Name
Symbol%Assets
- Moderna, Inc.MRNA6.39%
- Revolution Medicines, Inc.RVMD5.60%
- Sarepta Therapeutics, Inc.SRPT5.12%
- Regeneron Pharmaceuticals, Inc.REGN4.75%
- Merck & Co., Inc.MRK4.56%
- Incyte CorporationINCY4.29%
- GSK plcGSK4.15%
- SanofiSAN3.75%
- Roche Holding Ltd Dividend Right Cert.ROG3.72%
- Exelixis, Inc.EXEL3.67%
Technical Analysis of IDNA 2024-11-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2022-09-09 01:45
BlackRock Zeros in on Themed ETFs(Yahoo Finance)
- 2022-03-30 01:30
Vir Jumps 20% On S&P SmallCap 600 News(Yahoo Finance)
- 2022-02-25 08:59
Best Biotech ETFs for Q2 2022(Investopedia)
- 2021-12-05 21:15
BlackRock Releases Megatrends Report(Yahoo Finance)
- 2021-10-20 22:15
ETF Battles: ARKG Vs IDNA Vs GNOM(Yahoo Finance)
- 2020-05-18 03:42
- 2020-05-17 22:51
- 2019-12-22 23:00
- 2019-12-18 00:41
Best & Worst Monthly Performers: December 18 Edition(Yahoo Finance)
- 2019-11-25 05:55
Genomics ETFs Surge on CRISPR's Gene Editing Progress(Yahoo Finance)
- 2019-11-20 23:56
Best & Worst Monthly Performers: November 21 Edition(Yahoo Finance)
- 2019-11-04 00:00
Value Biotech ETFs & Stocks to Buy Now(Yahoo Finance)
- 2019-10-22 22:10
Biotech ETFs Surge on a Flurry of Positive News(Yahoo Finance)
- 2019-09-06 03:07
ETFs Poised to Benefit from Gene Editing Revolution(Yahoo Finance)
- 2019-09-04 03:18
ETFs to Gain From the Booming Genomics Market(Yahoo Finance)
Page 1 of 1
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.